Error: Could not add to watchlist. X

Dendreon Corp

+ Watchlist
DNR:GR
Ticker Delisted
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer.
ADDRESS
1301 2nd Avenue
Seattle, WA 98101
United States
PHONE
1-206-256-4545
  • Craig R Jalbert
    President/Treasurer/Secretary
  • Andrew S Sandler
    Exec VP/Chief Medical Officer
  • Lindsay Rocco
    Exec VP:Corporate Communications
  • William Monteith
    Exec VP:Technical Operations
  • Bill Jenkinson
    VP/Chief Marketing Officer
Show More